Overcoming tumor resistance mechanisms in CAR-NK cell therapy

Overcoming tumor resistance mechanisms in CAR-NK cell therapy

Despite the impressive results of autologous CAR-T cell therapy in refractory B lymphoproliferative diseases, CAR-NK immunotherapy emerges as a safer, faster, and cost-effective approach with no signs of severe toxicities as described for CAR-T cells. Permanently scrutinized for its efficacy, recent...

Full description

Bibliographic Details
Main Authors:	Antonio Valeri, Almudena García-Ortiz, Eva Castellano, Laura Córdoba, Elena Maroto-Martín, Jessica Encinas, Alejandra Leivas, Paula Río, Joaquín Martínez-López
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Immunology
Subjects:	chimeric antigen receptor (CAR) CAR NK cells hematologic tumor genome editing CRISPR/Cas9 tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.953849/full

Similar Items

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
by: Marta Włodarczyk, et al.
Published: (2022-12-01)

Current Progress of CAR-NK Therapy in Cancer Treatment
by: Zhaojun Pang, et al.
Published: (2022-09-01)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
by: Xinyu Wu, et al.
Published: (2022-12-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01)

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
by: Almudena García-Ortiz, et al.
Published: (2021-01-01)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
by: Yan Yang, et al.
Published: (2020-09-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Kevin Pan, et al.
Published: (2022-03-01)

Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment
by: Ishwar Navin, et al.
Published: (2020-12-01)

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets
by: Hee Young Kang, et al.
Published: (2023-01-01)

Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances
by: Adrian Kowalczyk, et al.
Published: (2024-01-01)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
by: Katharina Eva Ruppel, et al.
Published: (2022-03-01)

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
by: Ali Keshavarz, et al.
Published: (2022-09-01)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
by: Lara Herrera, et al.
Published: (2021-10-01)

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
by: Adrien Krug, et al.
Published: (2021-12-01)

Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review
by: Chinmayee Priyadarsini Dash, et al.
Published: (2024-04-01)

CAR-T: What Is Next?
by: Yi-Ju Chen, et al.
Published: (2023-01-01)

Generation of an NFκB-Driven Alpharetroviral “All-in-One” Vector Construct as a Potent Tool for CAR NK Cell Therapy
by: Loreen Sophie Rudek, et al.
Published: (2021-11-01)

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
by: Karama Makni Maalej, et al.
Published: (2023-01-01)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
by: Siyao Liu, et al.
Published: (2022-12-01)

Opportunities and challenges of combining adoptive cellular therapy with oncolytic virotherapy
by: Joseph A. Mamola, et al.
Published: (2023-06-01)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
by: Loredana Cifaldi, et al.
Published: (2023-06-01)

CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment
by: Dasom Kong, et al.
Published: (2024-05-01)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021-11-01)

Outsmarting trogocytosis to boost CAR NK/T cell therapy
by: Faezeh Ramezani, et al.
Published: (2023-11-01)

Mechanisms of Resistance to NK Cell Immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2020-04-01)

Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations
by: Swati Garg, et al.
Published: (2023-11-01)

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
by: Jessica Encinas, et al.
Published: (2023-08-01)

Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias
by: Elisaveta Voynova, et al.
Published: (2022-01-01)

Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland
by: Tomasz J. Ślebioda, et al.
Published: (2022-11-01)

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
by: Faroogh Marofi, et al.
Published: (2021-07-01)

Immunotherapy with NK cells: recent developments in gene modification open up new avenues
by: Lisa Marie Reindl, et al.
Published: (2020-01-01)

Biomarkers as targets for CAR-T/NK cell therapy in AML
by: Ruonan Shao, et al.
Published: (2023-06-01)

CAR-NK Cells: From Natural Basis to Design for Kill
by: Muhammad Babar Khawar, et al.
Published: (2021-12-01)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
by: Maria Karvouni, et al.
Published: (2022-02-01)

Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy
by: Kangdi Yang, et al.
Published: (2023-01-01)

CAR NK-сells for the treatment of hematological malignancies: A review
by: Irina V. Gribkova
Published: (2022-11-01)

A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia
by: Ilias Christodoulou, et al.
Published: (2023-06-01)

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01)

Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01)